➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
McKesson
Moodys
Harvard Business School

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

CHLOROPROCAINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Chloroprocaine Hydrochloride, and when can generic versions of Chloroprocaine Hydrochloride launch?

Chloroprocaine Hydrochloride is a drug marketed by Hospira and West-ward Pharms Int and is included in three NDAs.

The generic ingredient in CHLOROPROCAINE HYDROCHLORIDE is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.

Drug patent expirations by year for CHLOROPROCAINE HYDROCHLORIDE
Recent Clinical Trials for CHLOROPROCAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sintetica SAPhase 2/Phase 3
Sintetica SAPhase 1/Phase 2
The University of Texas Health Science Center, HoustonPhase 4

See all CHLOROPROCAINE HYDROCHLORIDE clinical trials

Pharmacology for CHLOROPROCAINE HYDROCHLORIDE
Drug ClassEster Local Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for CHLOROPROCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 087447-001 Apr 16, 1982 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
West-ward Pharms Int CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 040273-002 Sep 9, 1998 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Hospira CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 087446-001 Apr 16, 1982 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
West-ward Pharms Int CHLOROPROCAINE HYDROCHLORIDE chloroprocaine hydrochloride INJECTABLE;INJECTION 040273-001 Sep 9, 1998 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
McKesson
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.